“Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 2, no. 6, June 2009, https://doi.org/10.4081/hmr.v2i6.771.